We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Ligand Pharmaceuticals Incorporated (PK) | USOTC:LGNZZ | OTCMarkets | Right |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1325 | 0.13 | 0.14 | 0.00 | 13:14:51 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Ligand Pharmaceuticals Inc
(Name of Issuer)
Common Shares
(Title of Class of Securities)
53220K504
(CUSIP Number)
September 30, 2024
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☒ | Rule 13d-1(b) |
☐ | Rule 13d-1(c) |
☐ | Rule 13d-1(d) |
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Page 1 of 13
CUSIP No. 53220K504
1. |
Names of Reporting Persons
Macquarie Group Limited | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
| |||||
3. | SEC Use Only
| |||||
4. | Citizenship or Place of Organization
Sydney, New South Wales Australia |
Number of Shares Beneficially Owned by Each Reporting Person With |
5. | Sole Voting Power
0 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
0 | |||||
8. | Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
887,275 deemed beneficially owned due to reporting persons ownership of Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust whose individual holdings are shown on the following forms. | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
☐ | |||||
11. | Percent of Class Represented by Amount in Row (9)
4.86% | |||||
12. | Type of Reporting Person (See Instructions)
HC |
Page 2 of 13
CUSIP No. 53220K504
1. |
Names of Reporting Persons
Macquarie Management Holdings Inc | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
| |||||
3. | SEC Use Only
| |||||
4. | Citizenship or Place of Organization
State of Delaware |
Number of Shares Beneficially Owned by Each Reporting Person With |
5. | Sole Voting Power
887,275 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
887,275 | |||||
8. | Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
887,275 deemed beneficially owned due to reporting persons ownership of Macquarie Investment Management Business Trust | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
☒ | |||||
11. | Percent of Class Represented by Amount in Row (9)
4.86% | |||||
12. | Type of Reporting Person (See Instructions)
HC |
Page 3 of 13
CUSIP No. 53220K504
1. |
Names of Reporting Persons
Macquarie Investment Management Business Trust | |||||
2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☒ (b) ☐
| |||||
3. | SEC Use Only
| |||||
4. | Citizenship or Place of Organization
State of Delaware |
Number of Shares Beneficially Owned by Each Reporting Person With |
5. | Sole Voting Power
887,275 | ||||
6. | Shared Voting Power
0 | |||||
7. | Sole Dispositive Power
887,275 | |||||
8. | Shared Dispositive Power
0 |
9. |
Aggregate Amount Beneficially Owned by Each Reporting Person
887,275 | |||||
10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
☒ | |||||
11. | Percent of Class Represented by Amount in Row (9)
4.86% | |||||
12. | Type of Reporting Person (See Instructions)
IA |
Page 4 of 13
Item 1. | ||||||
(a) | Name of Issuer Ligand Pharmaceuticals Inc | |||||
(b) | Address of Issuers Principal Executive Offices 3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121 | |||||
Item 2. | ||||||
(a) | Name of Person Filing This Schedule 13G is jointly filed by Macquarie Group Limited, Macquarie Management Holdings Inc and Macquarie Investment Management Business Trust | |||||
(b) | Address of Principal Business Office or, if none, Residence The principal business address of Macquarie Group Limited is Level 1, 1 Elizabeth Street, Sydney, New South Wales, Australia. The principal business address of Macquarie Management Holdings Inc. and Macquarie Investment Management Business Trust is 610 Market Street, Philadelphia, PA 19106. | |||||
(c) | Citizenship Macquarie Group Limited - Sydney, New South Wales, Australia Corporation Macquarie Management Holdings Inc., Macquarie Investment Management Business Trust incorporated or formed under the laws of the State of Delaware. | |||||
(d) | Title of Class of Securities Common Stock | |||||
(e) | CUSIP Number 53220K504 | |||||
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |||||
(a) | ☐ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | ||||
(b) | ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | ||||
(c) | ☐ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | ||||
(d) | ☐ | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | ||||
(e) | ☒ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | ||||
(f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | ||||
(g) | ☒ | A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); | ||||
(h) | ☐ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | ||||
(i) | ☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | ||||
(j) | ☐ | A non-U.S. institution in accordance with § 240.13d1(b)(1)(ii)(J); | ||||
(k) | ☐ | Group, in accordance with § 240.13d1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d1(b)(1)(ii)(J), please specify the type of institution:____________________________ |
Page 5 of 13
Item 4. | Ownership | |||||
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | ||||||
(a) | Amount beneficially owned: See responses on the cover page hereto. | |||||
(b) | Percent of class: See responses on the cover page hereto. | |||||
(c) | Number of shares as to which the person has:
| |||||
(i) | Sole power to vote or to direct the vote See responses on the cover page hereto. | |||||
(ii) | Shared power to vote or to direct the vote 0 | |||||
(iii) | Sole power to dispose or to direct the disposition of See responses on the cover page hereto. | |||||
(iv) | Shared power to dispose or to direct the disposition of 0 | |||||
Item 5. | Ownership of Five Percent or Less of a Class | |||||
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following | ||||||
Item 6. | Ownership of More than Five Percent on Behalf of Another Person | |||||
Not applicable. | ||||||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person | |||||
See Exhibit A. | ||||||
Item 8. | Identification and Classification of Members of the Group | |||||
Not applicable. | ||||||
Item 9. | Notice of Dissolution of Group | |||||
Not applicable. |
Page 6 of 13
Item 10. | Certification | |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Macquarie Group Limited | November 1, 2024 | |||
Date | ||||
/s/ Philip Alexander |
/s/ Charles Glorioso | |||
Signature | Signature | |||
Philip Alexander Associate Director |
Charles Glorioso Division Director |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Macquarie Management Holdings, Inc. | November 1, 2024 | |||
Date | ||||
/s/ Marty Wolin |
||||
Signature | ||||
Marty Wolin Chief Compliance Officer |
||||
Macquarie Investment Management Business Trust | November 1, 2024 | |||
Date | ||||
/s/ Marty Wolin |
||||
Signature | ||||
Marty Wolin Chief Compliance Officer |
Page 7 of 13
EXHIBIT A
AGREEMENT TO FILE JOINT ACQUISITION STATEMENTS
AGREEMENT made this [7th] day of FEBRUARY, 2024 by and between Delaware Funds by Macquarie,® Optimum Fund Trust and Macquarie ETF Trust listed on Annex A hereto, Macquarie Investment Management Business Trust, Macquarie Management Holdings, Inc, and the Macquarie Parties listed on Annex B hereto (collectively referred to as the parties).
WHEREAS, the parties hereto may be deemed to be the direct or indirect beneficial owners of the same equity securities for the purpose of the reporting requirements of Section 13(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and
WHEREAS, the regulations promulgated under Section 13(d) of the Exchange Act permit the joining of such beneficial owners in the filing of a single Joint Acquisition Statement reporting such ownership to the Securities and Exchange Commission.
NOW, THEREFORE, in consideration of the mutual covenants herein contained, and each of the parties hereto intending to be legally bound, it is agreed as follows:
1. In the event that any two or more parties shall be deemed to be the direct or indirect beneficial owners of the same equity security required to be reported to the Securities and Exchange Commission such parties may join together in the filing of a Joint Acquisition Statement with respect to that security. Additional persons who may after the date hereof be deemed to be the direct or indirect beneficial owners of the same equity security as a party hereto and required to be reported to the Securities and Exchange Commission (a New Party) may be added as a party this agreement by signing a counterpart hereof. An amendment to this agreement is deemed effective upon the signature of such new party and the amendment of the applicable Annex which may be affixed to this agreement as amended. Each party hereto agrees that this agreement, as it may be amended from time to time as provided herein, is a valid and binding agreement of each such party.
2. With respect to each Joint Acquisition Statement in which a party joins, each party acknowledges that (a) it will be eligible under applicable regulations of the Securities and Exchange Commission to join in the filing and (b) it will be responsible for the timely filing of such statement and any amendments thereto and the completeness and accuracy of the information concerning such party; but each such party shall not be responsible for the completeness and accuracy of the information concerning the other parties making the filing, unless such party knows or has reason to believe that such information with respect to such other parties is inaccurate.
3. The parties consent to the inclusion of a copy of this agreement as an exhibit to any Joint Acquisition Statement filed on behalf of any of them.
Page 8 of 13
IN WITNESS WHEREOF, the parties hereto have executed this agreement by their duly authorized officers as of the date set forth above.
DELAWARE FUNDS® BY MACQUARIE (listed on Annex A hereto)
MACQUARIE ETF TRUST
OPTIMUM FUND TRUST
ATTEST BY:
DELAWARE FUNDS BY MACQUARIE® MACQUARIE ETF TRUST |
||||
/s/ Marty Wolin |
/s/ David Connor | |||
Signature | Signature | |||
Marty Wolin Chief Compliance Officer |
David Connor General Counsel | |||
OPTIMUM FUND TRUST | ||||
/s/ William Speacht |
/s/ A.G. Ciavarelli | |||
Signature | Signature | |||
William Speacht Chief Compliance Officer |
A.G. Ciavarelli General Counsel | |||
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | ||||
/s/ Marty Wolin |
/s/ David Connor | |||
Signature | Signature | |||
Marty Wolin Chief Compliance Officer |
David Connor General Counsel | |||
MACQUARIE MANAGEMENT HOLDINGS, INC. | ||||
/s/ Marty Wolin |
/s/ David Connor | |||
Signature | Signature | |||
Marty Wolin Chief Compliance Officer |
David Connor General Counsel |
Page 9 of 13
THE MACQUARIE PARTIES (LISTED ON ANNEX B HERETO)
ATTEST BY:
/s/ Philip Alexander |
/s/ Charles Glorioso | |||
Signature | Signature | |||
Philip Alexander Associate Director |
Charles Glorioso Division Director |
Page 10 of 13
Annex A Delaware Funds by Macquarie® and Macquarie ETF Trust
Delaware Group® Adviser Funds
Delaware Group® Cash Reserve
Delaware Group® Equity Funds II
Delaware Group® Equity Funds IV
Delaware Group® Equity Funds V
Delaware Group® Global & International Funds
Delaware Group® Government Fund
Delaware Group® Income Funds
Delaware Group® Limited-Term Government Funds
Delaware Group® State Tax-Free Income Trust
Delaware Group® Tax-Free Fund
Delaware Pooled® Trust
Delaware VIP® Trust
Voyageur Insured Funds
Voyageur Intermediate Tax Free Funds
Voyageur Mutual Funds
Voyageur Mutual Funds II
Voyageur Mutual Funds III
Voyageur Tax Free Funds
Ivy Funds
Ivy Variable Insurance Portfolios
Macquarie ETF Trust
Optimum Fund Trust
Page 11 of 13
Annex B the Macquarie Parties
Macquarie Group Limited
Macquarie Bank Limited
Macquarie Asset Management Holdings Pty Limited
Macquarie Asset Management US Holdings Pty Limited
Macquarie Affiliated Managers (USA) Inc.
Macquarie Affiliated Managers Holdings (USA) Inc.
Macquarie Americas Holdings Pty Ltd.
Macquarie B.H. Pty Limited
Macquarie FG Holdings Inc.
Macquarie Funding Holdings LLC
Macquarie Investment Management Europe Limited
Macquarie Investment Management Austria Kapitalanlage AG
Macquarie Investment Management Global Limited
Page 12 of 13
EXHIBIT B
Powers of Attorney for Macquarie Group Limited incorporated by reference to 13G filings made by Macquarie Group Limited on June 7, 2023.
Page 13 of 13
1 Year Ligand Pharmaceuticals (PK) Chart |
1 Month Ligand Pharmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions